Skip Navigation


Carcinogenesis Advance Access originally published online on April 30, 2009
Carcinogenesis 2009 30(7):1202-1208; doi:10.1093/carcin/bgp093
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
30/7/1202    most recent
bgp093v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Mense, S. M.
Right arrow Articles by Bhat, H. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mense, S. M.
Right arrow Articles by Bhat, H. K.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Vitamin C and {alpha}-naphthoflavone prevent estrogen-induced mammary tumors and decrease oxidative stress in female ACI rats

Sarah M. Mense, Bhupendra Singh, Fabrizio Remotti1, Xinhua Liu2 and Hari K. Bhat*

Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University, 60 Haven Avenue, B106, New York, NY 10032, USA
1 Department of Pathology, Columbia University Medical Center, New York, NY 10032, USA
2 Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY 10032, USA

* To whom correspondence should be addressed. Tel: +1 212 305 0528; Fax: +1 212 342 0450; Email: hb2009{at}columbia.edu

The mechanisms underlying the pathogenesis of estrogen-induced breast carcinogenesis remain unclear. The present study investigated the roles of estrogen metabolism and oxidative stress in estrogen-mediated mammary carcinogenesis in vivo. Female August Copenhagen Irish (ACI) rats were treated with 17β-estradiol (E2), the antioxidant vitamin C, the estrogen metabolic inhibitor {alpha}-naphthoflavone (ANF), or cotreated with E2 + vitamin C or E2 + ANF for up to 8 months. E2 (3 mg) was administered as an subcutaneous implant, ANF was given via diet (0.2%) and vitamin C (1%) was added to drinking water. At necropsy, breast tumor incidence in the E2, E2 + vitamin C and E2 + ANF groups was 82, 29 and 0%, respectively. Vitamin C and ANF attenuated E2-induced alterations in oxidative stress markers in breast tissue, including 8-iso-prostane F2{alpha} formation and changes in the activities of antioxidant enzymes superoxide dismutase and glutathione peroxidase. Quantification of 2-hydroxyestradiol (2-OHE2) and 4-hydroxyestradiol (4-OHE2) formation in breast tissue confirmed that ANF inhibited 4-hydroxylation of E2 and decreased formation of the highly carcinogenic 4-OHE2. These results demonstrate that antioxidant vitamin C reduces the incidence of estrogen-induced mammary tumors, increases tumor latency and decreases oxidative stress in vivo. Further, our data indicate that ANF completely abrogates breast cancer development in ACI rats. The present study is the first to demonstrate the inhibition of breast carcinogenesis by antioxidant vitamin C or the estrogen metabolic inhibitor ANF in an animal model of estrogen-induced mammary carcinogenesis. Taken together, these results suggest that E2 metabolism and oxidant stress are critically involved in estrogen-induced breast carcinogenesis.

Abbreviations: ACI, August Copenhagen Irish; ANF, {alpha}-naphthoflavone; CAT, catalase; E2, 17β-estradiol; ER, estrogen receptor; GPx, glutathione peroxidase; 8-isoPGF2{alpha}, 8-iso-prostane F2{alpha}; 2-OHE2, 2-hydroxyestradiol; 4-OHE2, 4-hydroxyestradiol; SOD, superoxide dismutase

Received February 27, 2009; revised April 9, 2009; accepted April 10, 2009.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.